What is the process of platelet aggregation?
Traditional approaches to monitor platelet aggregation involve exposure of platelets in suspension to a variety of stimuli ex vivo, a technique known as platelet aggregometry. Agonists used commonly include adenosine diphosphate (ADP), collagen, thrombin, and thromboxane A2, among others [166].
What receptor causes platelet aggregation?
Lysophosphatidic acid receptors (LPL-R) are members of a family of seven transmembrane receptors with a molecular weight of 38-40 kDa. They are expressed on activated platelets and act as autocrine agonists. They bring about shape changes, initiate release reactions and induce platelet aggregation.
How does cAMP prevent platelet aggregation?
ARC69931MX and clopidogrel by cAMP levels can inhibit human platelet aggregation through the activation of a separate G protein-coupled pathway (presumably involving Gs) and platelet P2Y12 receptor, respectively [51, 52].
What is cAMP in platelet aggregation?
An important mediator of the platelet activity is cyclic AMP (cAMP), which inhibits platelet aggregation. Intracellular cAMP levels are regulated via the Gs and Gi alpha subunits of heterotrimeric G proteins, which couple to adenylyl cyclase to respectively stimulate or inhibit cAMP production.
What is ADP pathway?
ADP can be converted, or powered back to ATP through the process of releasing the chemical energy available in food; in humans, this is constantly performed via aerobic respiration in the mitochondria. Plants use photosynthetic pathways to convert and store energy from sunlight, also conversion of ADP to ATP.
How do P2Y12 inhibitors work?
Thienopyridines inhibit the platelet activation and aggregation by antagonizing the platelet P2Y12 receptor. This prevents the binding of ADP to the receptor which attenuates platelet aggregation and reaction of platelets to stimuli of thrombus aggregation such as thrombin [4].
What is effect of reduced cAMP production on platelet aggregation?
High cAMP levels strongly inhibit platelet aggregation whereas reduced cAMP levels increase it. Of note, a reduction of platelet intracellular cAMP levels represents the mechanism mediating the pro-aggregant effects of several platelet agonists, particularly ADP 23, 24 .
What type of receptor is P2Y12?
G-inhibitory-protein receptor
The P2Y12 receptor is a G-inhibitory-protein receptor in the platelet membrane, which is activated by ADP and results in the inhibition of adenylyl cyclase, thereby inducing platelet aggregation [33,34]. Moreover, the activation of P2Y12 receptor hinders the antiplatelet effects of prostacyclin.
What is the difference between ADP and ATP?
Thus, ATP is the higher energy form (the recharged battery) while ADP is the lower energy form (the used battery). When the terminal (third) phosphate is cut loose, ATP becomes ADP (Adenosine diphosphate; di= two), and the stored energy is released for some biological process to utilize.
What converts ADP to ATP?
Most of the ATP in cells is produced by the enzyme ATP synthase, which converts ADP and phosphate to ATP. ATP synthase is located in the membrane of cellular structures called mitochondria; in plant cells, the enzyme also is found in chloroplasts.
Is clopidogrel a P2Y12 inhibitor?
P2Y12 receptor blockers are another group of antiplatelet drugs. This group of drugs includes: clopidogrel, ticlopidine, ticagrelor, prasugrel, and cangrelor.
What is P2Y12 platelet?
The P2Y12 receptor is a G-inhibitory-protein receptor in the platelet membrane, which is activated by ADP and results in the inhibition of adenylyl cyclase, thereby inducing platelet aggregation [33,34]. Moreover, the activation of P2Y12 receptor hinders the antiplatelet effects of prostacyclin.
What are P2Y12 receptor antagonists?
Why GTP is used instead of ATP?
When GTP instead of ATP is the phosphate donor the pH optimum is 6.5 instead of 7.4. In addition NH4+ inhibits the transfer of phosphate from GTP but not from ATP. More importantly, cyclic AMP only stimulates the transfer of phosphate from ATP not from GTP.